STACEY MCROBERTS: Open Payments
NPI 1134744378 · WILMINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 16 payments from 10 companies in 2025. Trend: 2023 $51 · 2024 $0 · 2025 $571
Food & beverage: $555Education: $16
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $155 |
| ACADIA Pharmaceuticals Inc | 1 | $121 |
| Calliditas Therapeutics US Inc. | 3 | $76 |
| Ardelyx, Inc. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Amgen Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| OPKO Pharmaceuticals, LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: SAPIEN 3 Ultra RESILIA, NUPLAZID, TARPEYO, IBSRELA, Kerendia, TAVNEOS, AREXVY, JYNARQUE.
Industry payments across OH — which companies pay providers there.
